Tenofovir alafenamide-related renal adverse events

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1889卷 / 1期
关键词：
D O I：
10.1007/s40278-022-08683-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
    Sano, Tomoya
    Kawaguchi, Takumi
    Ide, Tatsuya
    Amano, Keisuke
    Kuwahara, Reiichiro
    Arinaga-Hino, Teruko
    Torimura, Takuji
    LIFE-BASEL, 2021, 11 (03):
  • [22] Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
    Walti, Laura N.
    Steinrucken, Julia
    Rauch, Andri
    Wandeler, Gilles
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (11):
  • [23] Safety of tenofovir alafenamide (TAF) in patients with a history of proximal renal tubulopathy on tenofovir disoproxil fumarate (TDF)
    Hamzah, L.
    Jones, R.
    Bailey, A.
    Williams, D.
    Johnson, M.
    Ibrahim, F.
    Musso, C.
    Burling, K.
    Campbell, L.
    Post, F.
    HIV MEDICINE, 2019, 20 : 8 - 9
  • [24] Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate
    Campbell, Lucy
    Barbini, Birgit
    Burling, Keith
    Cromarty, Ben
    Hamzah, Lisa
    Johnson, Margaret
    Jones, Rachael
    Samarawickrama, Amanda
    Williams, Deborah
    Winston, Alan
    Post, Frank A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (02) : 214 - 219
  • [25] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [26] Not all is perfect with Tenofovir alafenamide
    Noe, S.
    Jonsson-Oldenbuettel, C.
    Jaeger, H.
    HIV MEDICINE, 2020, 21 (06) : E10 - E11
  • [27] Fanconi Syndrome and Tenofovir Alafenamide
    Alvarez, Hortensia
    Llibre, Josep M.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (08) : 598 - 599
  • [28] Bictegravir/emtricitabine/tenofovir alafenamide
    不详
    AUSTRALIAN PRESCRIBER, 2019, 42 (02) : 68 - 69
  • [29] Comparative evaluation of adverse drug reactions for tenofovir alafenamide and tenofovir disoproxil fumarate using the FAERS Database: a disproportionality analysis
    Zhu, Meng
    Jia, Lingjuan
    Wang, Yike
    Zhang, Yongsheng
    Lv, Shengxia
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [30] An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis
    Ugarte, Ainoa
    De la Mora, Lorena
    Martinez-Rebollar, Maria
    Mallolas, Josep
    Laguno, Montserrat
    ANTIVIRAL THERAPY, 2021, 26 (1-2) : 9 - 12
12345